Warning: The NCBI web site requires JavaScript to function. more...
Assessment of the pharmacokinetics and dynamics of two combination regimens of fosmidomycin-clindamycin in patients with acute uncomplicated falciparum malaria.
Ruangweerayut R, Looareesuwan S, Hutchinson D, Chauemung A, Banmairuroi V, Na-Bangchang K.
Malar J. 2008 Oct 31;7:225.
Related citations
Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria.
Na-Bangchang K, Ruengweerayut R, Karbwang J, Chauemung A, Hutchinson D.
Malar J. 2007 May 25;6:70.
Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria.
Borrmann S, Issifou S, Esser G, Adegnika AA, Ramharter M, Matsiegui PB, Oyakhirome S, Mawili-Mboumba DP, Missinou MA, Kun JF, Jomaa H, Kremsner PG.
J Infect Dis. 2004 Nov 1;190(9):1534-40. Epub 2004 Sep 21.
Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.
Borrmann S, Lundgren I, Oyakhirome S, Impouma B, Matsiegui PB, Adegnika AA, Issifou S, Kun JF, Hutchinson D, Wiesner J, Jomaa H, Kremsner PG.
Antimicrob Agents Chemother. 2006 Aug;50(8):2713-8.
Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children.
Borrmann S, Adegnika AA, Matsiegui PB, Issifou S, Schindler A, Mawili-Mboumba DP, Baranek T, Wiesner J, Jomaa H, Kremsner PG.
J Infect Dis. 2004 Mar 1;189(5):901-8. Epub 2004 Feb 16.
Pharmacokinetics of sequential and simultaneous treatment with the combination chloroquine and sulfadoxine-pyrimethamine in acute uncomplicated Plasmodium falciparum malaria in the Philippines.
Bustos DG, Lazaro JE, Gay F, Pottier A, Laracas CJ, Traore B, Diquet B.
Trop Med Int Health. 2002 Jul;7(7):584-91.
The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
Na-Bangchang K, Manyando C, Ruengweerayut R, Kioy D, Mulenga M, Miller GB, Konsil J.
Eur J Clin Pharmacol. 2005 Sep;61(8):573-82. Epub 2005 Jul 23.
Fosmidomycin for the treatment of malaria.
Wiesner J, Borrmann S, Jomaa H.
Parasitol Res. 2003 Jun;90 Suppl 2:S71-6. Epub 2002 Nov 30. Review.
Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O.
Malar J. 2009 Jun 8;8:125.
Short-course regimens of artesunate-fosmidomycin in treatment of uncomplicated Plasmodium falciparum malaria.
Borrmann S, Adegnika AA, Moussavou F, Oyakhirome S, Esser G, Matsiegui PB, Ramharter M, Lundgren I, Kombila M, Issifou S, Hutchinson D, Wiesner J, Jomaa H, Kremsner PG.
Antimicrob Agents Chemother. 2005 Sep;49(9):3749-54.
An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
Silachamroon U, Krudsood S, Thanachartwet W, Tangpukdee N, Leowattana W, Chalermrut K, Srivilairit S, Wilaiaratana P, Thimasarn K, Looareesuwan S.
Southeast Asian J Trop Med Public Health. 2005 May;36(3):591-6.
Pharmacokinetics of mefloquine when given as a single and two divided-dose regimens.
Na-Bangchang K, Molunto P, Banmairuroi V, Thanavibul A, Karbwang J.
Int J Clin Pharmacol Res. 1995;15(5-6):215-20.
Pharmacokinetics of a five-day oral dihydroartemisinin monotherapy regimen in patients with uncomplicated falciparum malaria.
Le Thi DT, Le NH, Nguyen CH, Phan Thi D, Na-Bangchang K.
Drug Metab Pharmacokinet. 2008;23(3):158-64.
Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
Gutman J, Green M, Durand S, Rojas OV, Ganguly B, Quezada WM, Utz GC, Slutsker L, Ruebush TK 2nd, Bacon DJ.
Malar J. 2009 Apr 9;8:58.
Pharmacokinetic investigation on the therapeutic potential of artemotil (beta-arteether) in Thai patients with severe Plasmodium falciparum malaria.
Li Q, Lugt CB, Looareesuwan S, Krudsood S, Wilairatana P, Vannaphan S, Chalearmrult K, Milhous WK.
Am J Trop Med Hyg. 2004 Dec;71(6):723-31.
Fosmidomycin for malaria.
Missinou MA, Borrmann S, Schindler A, Issifou S, Adegnika AA, Matsiegui PB, Binder R, Lell B, Wiesner J, Baranek T, Jomaa H, Kremsner PG.
Lancet. 2002 Dec 14;360(9349):1941-2.
Pharmacokinetics of mefloquine with dihydroartemisinin as 2-day regimens in patients with uncomplicated falciparum malaria.
Thuy le TD, Hung le N, Hung NC, Na-Bangchang K.
Southeast Asian J Trop Med Public Health. 2007 Mar;38(2):205-12.
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.
Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ.
Antimicrob Agents Chemother. 2000 Mar;44(3):697-704.
Pharmacokinetics of mefloquine alone or in combination with artesunate.
Karbwang J, Na Bangchang K, Thanavibul A, Back DJ, Bunnag D, Harinasuta T.
Bull World Health Organ. 1994;72(1):83-7.
Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.
Hombhanje FW, Linge D, Saweri A, Kuanch C, Jones R, Toraso S, Geita J, Masta A, Kevau I, Hiawalyer G, Sapuri M.
Malar J. 2009 Aug 12;8:196.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on